Omni Commerce Corp. (“Omni”, or the “Company”) (TSXV:OMNI, FRA:0MZA) is pleased to announce the appointment of Michael Hopkinson to its board of directors.

Mr. Hopkinson is a US licensed CPA in the state of New Hampshire with over 20 years of US tax and public company experience. Having spent over 11 years working primarily for the accounting industry’s Big 4, Mr. Hopkinson’s experience has been extensive in the mining, pharmaceutical and real estate business sectors. In the Cannabis sector Mr. Hopkinson currently serves and has served as Chief Financial Officer (CFO) for 1933 Industries Ltd. (August, 2015 to November, 2018) and The Weekend Unlimited Inc. (September, 2018 to present).

Having served as CFO on numerous pubic companies Mr. Hopkinson has comprehensive experience in US-Canada Cross-Border tax and repatriation planning, Financial Statement Reporting (Quarterly & Annual) and Capital Financing Activities;

A native of Edmonton, Alberta, Mr. Hopkinson has been resident in Vancouver, BC Canada for the past 20 years.

“We’re excited to welcome Michael to the board of Omni. His experience as a CPA as well as CFO of various public companies will serve Omni well”, commented Anthony Srdanovic, CEO.

About Omni

Omni is a publicly listed company currently listed on the TSX Venture Exchange, trading under the symbol “OMNI”. Omni is headquartered in Vancouver, British Columbia and is a reporting issuer in British Columbia and Alberta.



Per: “Anthony Srdanovic”

Anthony Srdanovic, CEO

For further information, please contact:

Anthony Srdanovic, CEO
Phone: (604) 506-0949

Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this news release.


Trading resumes in:

Company: Revive Therapeutics Ltd.

Keep reading... Show less


Revive Therapeutics Ltd. (” Revive ” or the ” Company “) (CSE:RVV) ( USA : RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that it has entered into an amended agreement with Canaccord Genuity Corp. and Leede Jones Gable Inc. as the co-lead underwriters (collectively, the ” Underwriters “), to increase the size of its previously announced offering of units (the ” Equity Units “) at a price of $0.50 per Equity Unit. Under the amended terms, the Underwriters have agreed to purchase, on a bought deal basis, 40,000,000 Equity Units for gross proceeds to the Company of $20,000,000 (the ” Offering “). The over-allotment option granted to the Underwriters will proportionately increase to 15% of the Offering.

Keep reading... Show less

The new dispensary brings expanded access for patients in the growing communities of Central Florida

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 77th nationwide. The new, 5,100 sq. ft. location marks the Company’s first in Summerfield expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”).

The Company announced today that its board of directors have approved a private placement of up to 15,000,000 units at a price of $.40 per unit for gross proceeds of up to $6,000,000. Each unit will consist of one common share of the Company and one share purchase warrant. Each share purchase warrant will be exercisable to purchase an additional common share at a fixed price of $.45 per share for a period of one year from closing.

Keep reading... Show less

The following issues have been halted by IIROC:

Company: Revive Therapeutics Ltd.

Keep reading... Show less